Rapport Therapeutics Inc.... (RAPP)
NASDAQ: RAPP
· Real-Time Price · USD
28.78
0.24 (0.84%)
At close: Oct 03, 2025, 3:59 PM
Rapport Therapeutics Common Stock Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
Net Income | -88.31M | -79.7M | -78.31M | -71.85M | -63.02M | -51.31M | -34.79M | -21.27M | -12.56M | -6.15M |
Depreciation & Amortization | 975K | 931K | 839K | 632K | 436K | 249K | 112K | 59K | 36K | 15K |
Stock-Based Compensation | 14.82M | 12.78M | 10.23M | 8.03M | 5.7M | 4.29M | 3.52M | 2.53M | 1.67M | 723K |
Other Working Capital | -1.09M | 3.09M | 1.69M | 2.21M | 630K | -307K | 1.29M | 75K | -1.58M | -422K |
Other Non-Cash Items | -4.47M | -5.53M | 1.06M | 506K | 6.18M | 7.84M | 3.06M | 2.89M | 2.77M | 1.78M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 818K | 4.07M | 1.34M | 1.94M | 948K | -83K | 2.65M | 708K | -1.58M | -422K |
Operating Cash Flow | -76.17M | -67.45M | -64.83M | -60.74M | -49.75M | -39.99M | -27.18M | -16.82M | -11.4M | -4.8M |
Capital Expenditures | -679K | -1.62M | -2.4M | -3.62M | -3.53M | -2.65M | -1.64M | -199K | -147K | -61K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -254.69M | -380.17M | -381.3M | -373.97M | -260.45M | -122.03M | -77.22M | n/a | n/a | n/a |
Sales Maturities Of Investments | 273.59M | 270.41M | 209.8M | 93.08M | 36.24M | 3.95M | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 4.3M | 4.21M | 3.77M | 3.77M | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 22.52M | -107.18M | -170.14M | -280.73M | -227.74M | -120.72M | -78.86M | -199K | -147K | -61K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -1K | -1K | n/a | n/a | -4K | -4K | -4K | -4K | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 221.63M | 221.91M | 221.63M | -134K | -76K | -399K | -134K | n/a | -58K | -18K |
Financial Cash Flow | -1.45M | 157.97M | 221.63M | 221.48M | 308.23M | 148.79M | 145.14M | 145.28M | 59.92M | 60.01M |
Net Cash Flow | -55.1M | -16.66M | -13.34M | -119.99M | 30.74M | -11.93M | 39.09M | 128.25M | 48.37M | 55.14M |
Free Cash Flow | -76.85M | -69.07M | -67.23M | -64.36M | -53.28M | -42.64M | -28.82M | -17.02M | -11.55M | -4.86M |